Joseph A. Aisner
#128,932
Most Influential Person Now
Joseph A. Aisner's AcademicInfluence.com Rankings
Joseph A. Aisnerphilosophy Degrees
Philosophy
#6178
World Rank
#9172
Historical Rank
Logic
#3367
World Rank
#4514
Historical Rank

Download Badge
Philosophy
Why Is Joseph A. Aisner Influential?
(Suggest an Edit or Addition)Joseph A. Aisner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. (1999) (1410)
- Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. (1977) (395)
- Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. (1984) (311)
- Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. (1979) (258)
- Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. (1989) (254)
- Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer. (2000) (242)
- Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum. (1985) (201)
- Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. (1976) (192)
- Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. (1980) (189)
- Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. (1997) (182)
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors (2010) (179)
- Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma (2001) (169)
- A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia. (1983) (164)
- Carcinomatous Leptomeningitis in Small Cell Lung Cancer: A Clinicopathologic Review of the National Cancer Institute Experience (1982) (160)
- Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. (1983) (153)
- Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B. (1993) (153)
- Current state of immunotherapy for non-small cell lung cancer. (2007) (149)
- Megestrol acetate in cancer anorexia and weight loss (2010) (147)
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer. (2018) (147)
- Overview of the changing paradigm in cancer treatment: oral chemotherapy. (2007) (146)
- Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. (1982) (130)
- Frozen autologous platelet transfusion for patients with leukemia. (1978) (129)
- Current approach to malignant mesothelioma of the pleura. (1995) (123)
- Esophagoscopy as a source of Pseudomonas aeruginosa sepsis in patients with acute leukemia: the need for sterilization of endoscopes. (1974) (119)
- Alloimmunization following platelet transfusion: the absence of a dose- response relationship (1981) (117)
- Alloimmunization following prophylactic granulocyte transfusion. (1979) (115)
- DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY (2002) (115)
- Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study. (1997) (114)
- Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. (1987) (112)
- A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. (1988) (112)
- High-dose megestrol acetate. A possible treatment for cachexia. (1986) (111)
- Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized (1981) (108)
- Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. (1983) (108)
- Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. (1998) (106)
- Commentary: current status of chemotherapy for non-small cell lung cancer. (1981) (106)
- High-time chemotherapy or high time for low dose. (2000) (105)
- Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non–Small Cell Lung Cancer (2010) (104)
- Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. (1976) (103)
- Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer. (1999) (102)
- Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion (1983) (96)
- Staging, prognostic factors, and special considerations in small cell lung cancer. (1988) (95)
- First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors (2017) (94)
- Performance status assessment among oncology patients: a review. (1986) (93)
- The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. (2000) (90)
- Meperidine for the treatment of shaking chills and fever. (1980) (90)
- Pericardial window for malignant pericardial effusion. (1980) (86)
- High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. (1981) (84)
- Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. (1993) (84)
- Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion. (1987) (83)
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5‐drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B study (1984) (77)
- High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. (2002) (75)
- Comprehensive textbook of thoracic oncology (1996) (74)
- CT of peritoneal mesothelioma: analysis of eight cases. (1982) (73)
- Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate. (2002) (73)
- Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis. (1975) (73)
- Chemotherapy in the treatment of malignant mesothelioma. (1981) (72)
- Peritoneal mesothelioma: natural history and response to chemotherapy. (1983) (72)
- Computed tomographic evaluation of carcinoma of the cervix. (1982) (70)
- Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. (2020) (70)
- Phase I clinical and pharmacologic trial of carboplatin daily for 5 days. (1984) (69)
- Surgery in acute leukemia: A review of 167 operations in thrombocytopenic patients (1987) (69)
- Overcoming bcl-2- and p53-mediated resistance in prostate cancer. (1999) (68)
- Dihydro‐5‐azacytidine and cisplatin in the treatment of malignant mesothelioma (1998) (68)
- Antiemetic studies: a methodological discussion. (1986) (67)
- Changing face of small-cell lung cancer: real and artifact. (2006) (67)
- Malignant mesothelioma. Current status and future prospects. (1978) (64)
- Pregnancy outcome in patients treated for Hodgkin's disease. (1993) (64)
- Clinical Experience with Transfusion of Cryopreserved Platelets (1976) (64)
- Successful transfusion of platelets cryopreserved for more than 3 years. (1979) (63)
- Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat. (1994) (62)
- The pharmacology of carboplatin. (1989) (62)
- Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia. (1976) (62)
- Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites. (1986) (62)
- Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized. (1981) (61)
- Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers (2016) (61)
- Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities. (1986) (60)
- Frozen Autologous Platelets in the Supportive Care of Patients with Leukemia (2003) (58)
- Empiric antibiotic therapy. (1978) (58)
- Tamoxifen withdrawal response. Report of a case. (1989) (57)
- Etoposide: current status and future perspectives in the management of malignant neoplasms (2004) (55)
- Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection. (1983) (54)
- Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. (2015) (54)
- Carboplatin in malignant mesothelioma: A phase II study of the cancer and leukemia Group B (2004) (53)
- Small cell carcinoma of the lung: influence of age on treatment outcome. (1987) (51)
- Mitomycin C and vinblastine chemotherapy for advanced breast cancer (1981) (50)
- Treatment of cancer anorexia with megestrol acetate: impact on quality of life. (1990) (48)
- Dosimetric Predictors of Symptomatic Cardiac Events After Conventional‐Dose Chemoradiation Therapy for Inoperable NSCLC (2018) (47)
- A Standardized Technique for Efficient Platelet and Leukocyte Collection Using the Model 30 Blood Processor (2003) (47)
- Etoposide. Current and future status (1991) (47)
- High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy. (1980) (46)
- Mesothelioma following Wilms' tumor in childhood (1984) (46)
- Volume determinations in computed tomography. (1982) (46)
- Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741. (1999) (45)
- Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma (1984) (44)
- Appetite stimulation and weight gain with megestrol acetate. (1990) (43)
- Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation. (2015) (42)
- Granulocyte transfusion therapy and amphotericin B: Adverse reactions? (1989) (42)
- CT of malignant pleural mesothelioma. (1983) (41)
- A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies (2006) (41)
- Chemotherapy versus chemoimmunotherapy for small‐cell undifferentiated carcinoma of the lung (1980) (41)
- Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors (1984) (41)
- Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer. (2015) (41)
- Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. (1975) (40)
- Megestrol acetate-induced differentiation of 3T3-L1 adipocytes in vitro. (1988) (40)
- Current status of high-dose progestins in breast cancer. (1990) (40)
- A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. (1989) (40)
- Potential HLA‐matched platelet donor availability for alloimmunized patients (1983) (40)
- High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients. (1984) (39)
- Granulocyte Transfusions: Evaluation of Factors Influencing Results and a Comparison of Filtration and Intermittent Centrifugation Leukapheresis (1978) (39)
- Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. (1983) (38)
- High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients (1984) (38)
- Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer. (1982) (38)
- Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. (1990) (37)
- Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration (2019) (37)
- Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer. (1995) (37)
- High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234. (1999) (36)
- Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxide (1982) (35)
- Possible pulmonary toxicity secondary to vinblastine (1982) (35)
- Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281. (1995) (34)
- Phase II trial of carboplatin in non-small cell lung cancer. (1986) (33)
- Studies of high-dose megestrol acetate: potential applications in cachexia. (1988) (33)
- Carboplatin: the experience in head and neck cancer. (1989) (33)
- A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer. (1989) (32)
- High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities. (1987) (32)
- Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study. (1992) (32)
- The Effect of Hydroxyethyl Starch on In Vitro Platelet and Granulocyte Function (2003) (31)
- Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081. (1987) (31)
- Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. (1986) (31)
- Clinical and Biological Activity of Soy Protein Powder Supplementation in Healthy Male Volunteers (2007) (31)
- Chemoradiotherapy for the treatment of regionally advanced head and neck cancers. (1994) (31)
- Multiple sequential biomarkers in monitoring patients with carcinoma of the lung. (1984) (31)
- Reversal of granulocyte adherence to nylon fibers using local anesthetic agents: possible application to filtration leukapheresis. (1977) (30)
- Computed tomography of the chest in small cell lung cancer: potential new prognostic signs. (1984) (30)
- Alloimmunization following platelet transfusion: the absence of a dose-response relationship. (1981) (30)
- Leptomeningeal carcinomatosis in small cell carcinoma of the lung. (1981) (30)
- Sustained post‐transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia (1983) (30)
- Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer. (1981) (30)
- Restaging laparotomy in the management of the non-Hodgkin lymphomas. (1982) (30)
- Preliminary safety results of a phase II trial comparing two schedules of lapatinib (GW572016) as first line therapy for advanced or metastatic non-small cell lung cancer (2005) (29)
- Phase Ib/II study of hydroxychloroquine in combination with chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC). (2019) (29)
- Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study (2010) (29)
- Cisplatin for small-cell lung cancer. (1989) (28)
- Treatment of chemotherapy extravasation: current status. (1984) (28)
- Use of the computed tomographic whole body scanner to stage and follow patients with advanced ovarian carcinoma. (1980) (27)
- A novel paradigm in the treatment of oligometastatic non-small cell lung cancer. (2011) (27)
- Pharmacokinetics of paclitaxel and carboplatin in combination. (1995) (27)
- Patterns of recurrence for cancer of the lung and esophagus (1983) (27)
- Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma. (2003) (27)
- Chemotherapy Versus Chemoimmunotherapy (CAF v CAFVP v CMF Each t MER) for Metastatic Carcinoma of the Breast: A CALGB Study (1987) (26)
- A clinical program of platelet cryopreservation. (1982) (26)
- Abdominal CT in the staging of small-cell carcinoma of the lung: incidence of metastases and effect on prognosis. (1987) (26)
- Transtracheal selective bronchial brushing for pulmonary infiltrates in patients with cancer. (1976) (26)
- High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia. (1980) (26)
- Platelet transfusion therapy for patients with leukemia. (1978) (26)
- Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma (2001) (25)
- cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study. (1979) (25)
- Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer. (1995) (25)
- Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease. (1996) (25)
- Combined chemotherapy and radiation in locally advanced non-small cell lung cancer. (1994) (24)
- High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer. (1986) (24)
- High-dose megestrol acetate in the treatment of advanced breast cancer. (1988) (24)
- Torulopsis glabrata pneumonitis in patients with cancer. Report of three cases. (1974) (24)
- Identification of new drugs in small cell lung cancer: phase II agents first? (1987) (23)
- Carboplatin in the treatment of squamous cell head and neck cancers. (1992) (23)
- Appetite stimulation with megestrol acetate in cachectic cancer patients. (1986) (23)
- Horizontal pigmented banding of the nails in association with adriamycin chemotherapy. (1977) (23)
- Lung cancer as a complication of prolonged survival in patients with lymphoma. (1982) (23)
- Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140. (2003) (23)
- Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer. (1983) (23)
- The Effect of Dimethyl Sulfoxide on In Vitro Platelet Function (1976) (22)
- CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. (1982) (22)
- Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival. (1979) (22)
- A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib: a Brief Report. (2019) (22)
- Phase IB study of eribulin mesylate in combination with carboplatin in patients with advanced solid tumors. (2010) (21)
- Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501) (2014) (21)
- Platinum compounds. (1989) (21)
- PLATELET CRYOPRESERVATION USING DIMETHYL SULFOXIDE (1983) (20)
- Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer. (2018) (20)
- Doxorubicin, cyclophosphamide, etoposide and platinum, doxorubicin, cyclophosphamide and etoposide for small-cell carcinoma of the lung. (1986) (20)
- Tamoxifen in advanced male breast cancer. (1979) (20)
- A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors (2019) (20)
- Combined modalities in the treatment of head and neck cancers. (1995) (19)
- Lung cancer: recent changes and expectations of improvements. (1993) (19)
- Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia (2008) (19)
- Platelet transfusion therapy. (1977) (18)
- High-dose chemotherapy without autologous bone marrow transplantation in melanoma. (1986) (18)
- Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase I and II resistance: a pharmacodynamically based Phase I trial. (2003) (18)
- Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast. (1991) (18)
- A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck. (1997) (18)
- 242 Promising long term outcome of weekly paclitaxel and carboplatin with simultaneous thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (NSCLC) (1997) (17)
- The use of computed body tomography in malignant melanoma. (1988) (17)
- First-inHuman Clinical Trial of Oral ONC 201 in Patients with Refractory Solid Tumors (2019) (17)
- European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. (1994) (17)
- Phase I trial of N-methylformamide (NMF, NSC 3051). (1985) (16)
- Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia (2004) (16)
- Immunomodulation of Interleukin‐2 by Cyclophosphamide: A Phase IB Trial (1993) (15)
- Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen. (1997) (15)
- A Comparison of Platelets Prepared by the Haemonetics Model 30 and Multiunit Bag Plateletpheresis (1979) (15)
- A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors (2019) (15)
- Vandetanib Plus Chemotherapy for Induction Followed by Vandetanib or Placebo As Maintenance for Patients with Advanced Non–Small-Cell Lung Cancer: A Randomized Phase 2 PrECOG Study (PrE0501) (2013) (15)
- Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma (2004) (15)
- A phase I trial of continuous infusion VP16-213 (Etoposide) (2004) (14)
- The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients (1984) (14)
- Sample Size and Power Calculations (2021) (14)
- Tumors of the Pleura and Mediastinum (2008) (14)
- Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia (2008) (13)
- Exposure-response and PD-L1 expression analysis of second-line avelumab in patients with advanced NSCLC: Data from the JAVELIN Solid Tumor trial. (2017) (13)
- A study of HLA antigens and haplotypes in a population of Caucasians with acute non-lymphocytic leukemia. (1979) (12)
- Phase I trial of dihydroxyanthracenedione. (1981) (12)
- Gravity leukapheresis--a simple method of leukocyte collection for transfusion or in vitro study. (1979) (12)
- Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy. (2003) (12)
- Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non–Small Cell Lung Cancer (2016) (12)
- Mastectomy as an adjunct to combination chemotherapy. (1978) (12)
- Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing Data. (2018) (11)
- Pemetrexed for diffuse malignant pleural mesothelioma. (2002) (11)
- Phase I trial of pentamethylmelamine in patients with previously treated malignancies. (1980) (11)
- Phase I trial of menogaril administered as an intermittent daily infusion for 5 days. (1986) (11)
- Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer (1992) (11)
- Phase I trial of aclacinomycin A. (1982) (10)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one (2016) (10)
- Treatment of limited-disease small cell lung cancer. (1992) (10)
- Modern radiotherapy using image guidance for unresectable non-small cell lung cancer can improve outcomes in patients treated with chemoradiation therapy. (2016) (10)
- Donor reaction to hydroxyethyl starch during granulocytap heresis (1984) (10)
- Initial Observations on the Effects of Δ9‐Tetrahydrocannabinol on the Plasma Pharmacokinetics of Cyclophosphamide and Doxorubicin (1981) (10)
- A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443. (1990) (10)
- Effect of 13-cis-retinoic acid and α-interferon on transforming growth factor in patients with rising prostate-specific antigen (1997) (10)
- Acquired toxoplasmic lymphadenitis with demonstration of the cyst form. (1983) (9)
- Protein Calorie Malnutrition and Cancer Therapy (1992) (9)
- Current status of granulocyte transfusion therapy. (1977) (9)
- Prospective phase I multi-institutional trial of PD-1 blockade with pembrolizumab during concurrent chemoradiation for locally advanced, unresectable non-small cell lung cancer. (2019) (9)
- A Novel Paradigm in the Treatment of Oligometastatic Non-small Cell Lung Cancer (2008) (9)
- Chemoimmunotherapy for advanced breast cancer: A randomized comparison of 6 combinations (CMF, CAF vs CAFVP) each with or without MER immunotherapy. A CALGB study (1981) (9)
- Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study. (1996) (9)
- Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy. (2020) (9)
- Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes. (2018) (8)
- Cancer Treatment Research (1980) (8)
- The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients. (1984) (8)
- Phase II study of caracemide in advanced or recurrent non-small cell lung cancer. (1987) (8)
- Modulation of autophagy with hydroxychloroquine in patients with advanced non-small cell lung cancer (NSCLC): A phase Ib study. (2018) (8)
- Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresis (1981) (8)
- Orthostatic hypotension during combination chemotherapy with vincristine (NSC-67574). (1974) (8)
- A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung. (1982) (8)
- Staging of small cell lung cancer: do we need a new staging system? (1989) (8)
- A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide (2004) (8)
- Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung (1983) (8)
- A phase II trial of m‐AMSA in the treatment of advanced gynecologic malignancies (1982) (7)
- COMPUTED TOMOGRAPHIC DEMONSTRATION OF PERITONEAL MESOTHELIOMA (1981) (7)
- Increased leukocyte alkaline phosphatase activity following transfusion of leukocytes from a patient with chronic myelogenous leukemia. (1979) (7)
- Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung. (1981) (7)
- Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma. (1982) (7)
- Combined-modality therapies for non-small cell lung cancer. (1992) (7)
- CTEP #8342 autophagy modulation with antiangiogenic therapy: A phase I trial of sunitinib (Su) and hydroxychloroquine (HCQ). (2013) (6)
- Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. (1982) (6)
- Therapeutic approach to malignant mesothelioma. (1989) (6)
- Statistical Design and Analysis of Clinical Trials: Principles and Methods (2015) (6)
- Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapy. (1986) (6)
- Paclitaxel in head and neck and other cancers: future prospects. (1997) (6)
- Histocompatible platelet transfusion for patients with leukemia (1982) (6)
- Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (2020) (6)
- Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma. (1982) (6)
- Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer. (1987) (6)
- CT Screening for Lung Cancer: Are We Ready for Wide-Scale Application? (2007) (6)
- Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma. (1980) (6)
- Asbestos-Related Malignancy (1987) (6)
- Small bowel obstruction as a late complication of the treatment of Hodgkin's disease. (1990) (5)
- Combining radiation therapy and immunotherapy for lung cancers: a narrative review (2020) (5)
- Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion (2004) (5)
- Phase I Neoadjuvant Study of Intravesical Recombinant Fowlpox-GM-CSF (rF-GMCSF) or Fowlpox-TRICOM (rF-TRICOM) in Patients with Bladder Carcinoma (2019) (5)
- Phase Ib extension study of eribulin mesylate in combination with carboplatin in patients with chemotherapy-naive advanced non-small cell lung cancer (NSCLC). (2013) (5)
- Erratum to current state of immunotherapy for non-small cell lung cancer. (2017) (5)
- Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma (2004) (5)
- Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung (1981) (4)
- Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma. (1981) (4)
- Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma. (1991) (4)
- Treatment of advanced non-small cell lung cancer with bisantrene. (1983) (4)
- High-dose 6-mercaptopurine in advanced refractory cancer. (1978) (4)
- Doxorubicin, cyclophosphamide and VP16-213 (ACE) in the treatment of small cell lung cancer (2004) (4)
- The potential of megestrol acetate in the treatment of cancer cachexia. (1989) (4)
- Human Pharmacokinetics and Correlation With Clinical Toxicities of the Anthracycline Antibiotic Menogaril (7-Omen) (1985) (4)
- Inflammatory changes related to active tuberculosis: confusion with oat cell carcinoma of the lung on cytology specimens. (1978) (4)
- Combination chemotherapy of advanced breast cancer with adriamycin and VP 16-213 (1979) (4)
- Failure of Postfiltration Leukapheresis Plasma to Increase Granulocyte Yields (1977) (4)
- A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer (1991) (4)
- Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution (2019) (4)
- Breast cancer therapy in the elderly. (1993) (3)
- Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy (2016) (3)
- Current issues associated with oral chemotherapy: a roundtable discussion. (2007) (3)
- E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer (2013) (3)
- PRELIMINARY-OBSERVATIONS ON THE EFFECTS OF DIMETHYLSULFOXIDE ON THE METABOLISM AND DISTRIBUTION OF ADRIAMYCIN (1981) (3)
- A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma. (2012) (3)
- Nutritional concerns in cancer patients. (1989) (3)
- Current staging of lung cancer: an overview of current and newer approaches. (1989) (3)
- Paclitaxel in head and neck cancer and other tumor types: chairmen's introduction. (1997) (3)
- Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. (1983) (3)
- Abstract PulmonaryThoracoscopic staging and diagnosis for lung cancer: University of Maryland experience (1994) (3)
- Rational Approach to Granulocyte Transfusion Therapy (1980) (3)
- Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy (2017) (3)
- Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non–Small Cell Lung Cancer Are Associated With Decreases in Overall Survival (2018) (3)
- Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: (2011) (3)
- Streptozotocin: an inactive agent in small cell carcinoma. (1979) (3)
- Current approaches to small cell lung cancer (1992) (3)
- Cranial irradiation in adults diagnosed with acute myelogenous leukemia presenting with hyperleukocytosis and neurologic dysfunction (2014) (3)
- Strategies for new drug identification in small cell lung cancer (1993) (2)
- Safety and pharmacodynamics of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration. (2018) (2)
- Use of computed body tomography in malignant melanoma (1988) (2)
- Topoisomerase Inhibitors Conference University of Maryland Cancer Center, 27-30 October 1993, Monterey, California, USA (1994) (2)
- Should we intensify the treatment of small cell lung cancer? (1989) (2)
- 9 Radiation therapy with concurrent weekly carboplatin and paclitaxel in advanced stage unresectable squamous cell carcinomas of the head and neck (1999) (2)
- Computed Tomography in the Evaluation of Lung Cancer (1986) (2)
- Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer (2021) (2)
- Management of disseminated carcinoma of the breast (1978) (2)
- Phase II Trial of N-Methylformamide in Advanced Renal Cancer (1989) (2)
- Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survival. (2016) (2)
- Targeted treatment of RAI-resistant metastatic thyroid cancer postcomprehensive genomic profiling. (2014) (2)
- Tumor volume and treatment outcome in small cell lung carcinoma. (1989) (2)
- Severe skin necrosis produced by piperazinedione extravasation. (1980) (2)
- Potential applications of high-dose megestrol acetate in breast cancer. (1992) (2)
- A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer (2019) (2)
- Combined modalities in the treatment of small cell carcinoma of the lung. A review of current standings. (1988) (2)
- Weekly paclitaxel/carboplatin and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck (1998) (1)
- Current Status and Future Prospects (2017) (1)
- Filtration leukapheresis (FL) and granulocytes. (1978) (1)
- Specialty rounds. Management of disseminated carcinoma of the breast. (1978) (1)
- Update in Combined Modality (1986) (1)
- Letter: Filtration leukopheresis. (1976) (1)
- Current concepts in the therapy of small cell lung cancer (1986) (1)
- Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy. (2019) (1)
- Statistical Design, Monitoring, and Analysis of Clinical Trials (2021) (1)
- Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: are we ready for phase III? (2005) (1)
- P2.16-001 Liposomal Bupivacaine (Exparel) Reduces Thoracic Surgery Post-Operative Pain and Reduces Length of Stay, a Retrospetive Study (2017) (1)
- Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer. (1985) (1)
- Statistical Significance and p-Values (2021) (1)
- Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC). (2017) (1)
- Ambulatory pulse oximetry as a clinical aid for the diagnosis and treatment response of radiation pneumonitis. (2015) (1)
- Abstract 3513: Hydroxychoroquine (HCQ) modulates autophagy in melanoma: preliminary results of a phase 0 trial in patients with resectable melanoma. (2013) (1)
- Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients. (2017) (1)
- Paclitaxel and carboplatin with simultaneous thoracic irradiation in regionally advanced non-small cell lung cancer (1997) (1)
- Principles of Infection Management and Prevention (1983) (1)
- Receipt of recommended surveillance with imaging in elderly survivors of early stage non-small cell lung cancer. (2018) (1)
- Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer. (2006) (1)
- A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies (2021) (1)
- In response to Dr. Ochel (2001) (1)
- A phase I trial of MK-2206 and hydroxychloroquine(HCQ) in solid tumors, melanoma, renal, and prostate cancer to examine the role of autophagy in tumorigenesis. (2014) (1)
- Vitamin B6 derivatives. Synthesis of N-[2-methyl-3-hydroxy-5-(2-carboxyethyl)-4-pyridylmethyl] phenylalanine and related compounds (1969) (1)
- Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer. (2019) (1)
- Impact of Metformin Use on Survival in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy (2014) (1)
- Breast Cancer Screening for Elderly Women-Reply (1994) (1)
- Interferon alpha + 13-cis-retinoic acid modulation of BCL-2 + paclitaxel for recurrent SCLC (2008) (0)
- Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer. (1982) (0)
- Phase I Clinical and Pharmacokinetic Study of Hexamethylene Bisacetamide (NSC 95580) Administered as a Five-Day Continuous Infusion1 (2006) (0)
- Scientific Reporting Questioned-Reply (1978) (0)
- Therapy to promote weight gain in cancer and acquired immunodeficiency syndrome patients: A panel discussion (Part 1) (1990) (0)
- Pulmonary function to measure response in small cell lung cancer. (1985) (0)
- Overexpression of Excision Repair Cross Complementing-1 Gene May Predict Local Recurrence After Definitive Chemoradiation for Unresectable Non-Small Cell Lung Cancer (2015) (0)
- THANKS TO REVIEWERS1999 (1999) (0)
- CT Evaluation of Patients During Treatment of Advanced Non‐Small Cell Lung Carcinoma (1986) (0)
- Evaluation of barriers to clinical trial enrollment through a novel pharmacy quality assurance tool (2007) (0)
- 410 Vandetanib, docetaxel and carboplatin followed by maintenance vandetanib or placebo in patients with stage IIIB, IV or recurrent non-small cell lung cancer (NSCLC): a randomized phase II study (PrE0502) by PrECOG, LLC (NCT006872970) (2010) (0)
- Thanks to authors and peer reviewers (2007) (0)
- Current Approach toMalignant Mesothelioma ofthePleura (2017) (0)
- A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC) (2007) (0)
- Combination chemotherapy for small cell lung cancer (SCLC) with platinol, doxorubicin, cyclophosphamide and etoposide (PACE): Results of 2 studies (1989) (0)
- A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850 (2023) (0)
- Phase I I T rial o f G emcitabine P lus C isplatin i n P atients With M etastatic U rothelial C ancer (2000) (0)
- Concepts and Methods of Statistical Designs (2021) (0)
- Tumor Volume Reduction Evaluated by CBCT during SBRT Treatment for Stage I/II NSCLC (2017) (0)
- Treatment Approaches for Lung Cancer Patients in a Community Hospital (1986) (0)
- BREAST CANCER SCREENING FOR ELDERLY WOMEN. AUTHOR'S REPLY (1994) (0)
- Receipt of recommended surveillance with imaging in survivors of early stage non-small cell lung cancer. (2017) (0)
- [Chemotherapy in recurrent and inoperable breast neoplasms]. (1978) (0)
- Asbestos-related neoplasms. Introduction. (1981) (0)
- Dose-Response T rial o f M egestrol A cetate i n A dvanced Breast C ancer: C ancer a nd L eukemia G roup B Phase I II S tudy 8 741 (1999) (0)
- Author/Subject Indexes (1992) (0)
- Abstract B123: A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors (2009) (0)
- FP03.02 A Phase I Trial of Atezolizumab and Varlilumab in Combination With Radiation in Patients with Metastatic Non-Small Cell Lung Cancer (2021) (0)
- Treatment of patients with breast cancer or prostate cancer: A panel discussion (part 2) (1990) (0)
- Impact of Target Volume Margins on Locoregional Control and Acute Toxicity for Unresectable Non-Small Cell Lung Cancer (2018) (0)
- Monitoring the Maximum Information and Adaptive Sample Size Designs (2021) (0)
- A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)—Final report (2008) (0)
- A Support Vector Machine based Prediction Model for Discrimination of Malignant Pulmonary Nodules from Benign Nodules (2016) (0)
- 2879 High prevalent BRAF alterations and tert promoter mutations in papillary thyroid carcinoma (2015) (0)
- P-441 Weekly docetaxel (TXT) and cisplatin (CIS) for chemonaivepatients (Pts) with advanced non-small cell lung cancer (NSCLC) (2005) (0)
- Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer (2014) (0)
- Phase I Trial of 5‐Day Continuous Infusion Aziridinylbenzoquinone (AZQ, Diazaquone, NSC 182968) (1986) (0)
- An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012. (2013) (0)
- Daily Image-Guidance with Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung Cancer (2018) (0)
- Regression Analysis of Survival Data (2021) (0)
- Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer (2020) (0)
- A phase II clinical trial of gemcitabine and imatinib mesylate for patients with recurrent non-small cell lung cancer (NSCLC) (2008) (0)
- Sequential Designs and Methods—Part II: Monitoring Safety and Futility (2021) (0)
- granulocytes to sites of infection Alloimmunization prevents the migration of transfused indium-111- labeled (2011) (0)
- Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (2020) (0)
- Therapy for small cell and non-small cell lung cancer. (1990) (0)
- Estimand, Intercurrent Events, and Missing Data (2021) (0)
- Seamless Phase II/III: Select-the-Winner Design (2021) (0)
- Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma (2019) (0)
- Sequential Designs and Methods—Part III: Classical Group Sequential Trials (2021) (0)
- Is there a therapeutic benefit for patients participating in modern phase I trials? (2011) (0)
- Comparison of the demographics of patients enrolled (E) versus those not enrolled (NE) on therapeutic clinical trials at a comprehensive cancer center (2007) (0)
- SCAB (streptozotocin, CCNU, adriamycin, bleomycin) for advanced untreated Hodgkin's disease (1978) (0)
- P-440 Cell culture based sequenced gemcitabine (G), carboplatin (C)and paclitaxel (P); GCP for advanced stage IV non-small cell lung cancer (NSCLC) (2005) (0)
- K-ras mutation for prediction of response to chemotherapy plus autophagy inhibition in NSCLC. (2014) (0)
- Intravenous Gammaglobulin in Alloimmunized Platelet Transfusion Recipients (2017) (0)
- P2-225: A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC) (2007) (0)
- Phase i trial of 5 day continuous infusion hexamethylenebisacetamide nsc 95580 (1986) (0)
- Variations in Initiation Dates of Chemotherapy and Radiation Therapy is Associated With Decreases in Overall Survival (2017) (0)
- Clinical Trials with Predictive Biomarkers (2021) (0)
- PB1737 MULTICENTER, RANDOMIZED, CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE AND FOOD EFFECT ON THE BIOAVAILABILITY OF CC-486 (ORAL AZACITIDINE) TABLETS IN ADULT CANCER PATIENTS (2019) (0)
- Autophagy as a therapeutic target in cancer treatment. (2010) (0)
- Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer. (2021) (0)
- JAMA Oncology Peer Reviewers in 2017. (2018) (0)
- Steroid Therapy for Acute Respiratory Distress Syndrome in Nonseptic Lobectomy Patients (2012) (0)
- Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Unresectable Non-Small Cell Lung Cancer Patients (2015) (0)
- Analysis of Covariance and Stratified Analysis (2021) (0)
- Contents, Supplement 2, 1992 (1992) (0)
- CTEP #8850: A phase I trial of riluzole and sorafenib in patients with advanced solid tumors. (2015) (0)
- Clinical Characteristics and Dose Volume Histogram Parameters Associated With Pleural Effusion in Non-Small Cell Lung Cancer Patients Treated With Chemoradiation Therapy (2015) (0)
- Dosimetric Predictors of Symptomatic Cardiac Events Among Patients Receiving Conventional-Dose Radiation Therapy for Inoperable Non-Small Cell Lung Cancer (2018) (0)
- Training and oncologists' changing attitudes toward their own cancer therapy. (1985) (0)
- Thanks to Reviewers2015 (2015) (0)
- Predicting Clinical Outcomes of Patients with Stage III Non-Small-Cell Lung Cancer Treated with Concurrent Chemoradiation with and without PD-1/PD-L1 Inhibitors Using Cone Beam Computed Tomography (2020) (0)
- Multiplicity Issues and Methods for Controlling the Type I Error Rate (2021) (0)
- Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives (2020) (0)
- A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors. (2019) (0)
- Effect of P-30 protein and tamoxifen on transforming growth factor-β1 in patients with rising prostate specific antigen (2001) (0)
- European School of Oncology First Euro-American Forum Treatment on Lung Cancer (2003) (0)
- Effect of Soy Protein on Testosterone Levels (2007) (0)
- JAMA Peer Reviewers in 2018. (2019) (0)
- Clinical Significance of Pretreatment Tumor Growth Rate for Locally Advanced NSCLC (2017) (0)
- Sequential Designs and Methods—Part I: Expected Sample Size and Two-Stage Phase II Trials in Oncology (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph A. Aisner?
Joseph A. Aisner is affiliated with the following schools: